It was the second attempt, after a scheduled liftoff last week was postponed because of technical issues.
The news: India’s Chandrayaan-2 mission to the moon launched at 04.13 EDT today from the Sriharikota space station in the country’s southeastern coastal state of Andhra Pradesh.
Second go: The launch was due to take place exactly a week ago on July 15, but it had to be postponed just 56 minutes before launch because of a leak from a helium gas bottle in the rocket’s engine, according to the Times of India. It was simple to fix, but left unresolved, it could have resulted in total failure, a source from the Indian space agency Isro told the BBC.
Two firsts: If successful, it would be the first Indian spacecraft to land on the moon, and the first ever to land on the moon’s south pole. It would join a club of just three countries so far to land on the moon (the US, China, and the Soviet Union). The lander (named Vikram, after Isro’s founder) is scheduled to touch down on September 6 or 7 between two of the moon’s craters, Simpelius N and Manzinus C.
The mission: There are three components: the orbiter, the lander, and the rover. The lander will search for water and minerals, and measure moonquakes, while the orbiter will spend a year taking images of the moon’s surface. The rover, which has a life span of just 14 days, will roam up to half a kilometer from the lander, taking pictures and collecting data to send back to Earth. Chandrayaan-1, the country’s first moon mission in 2008, contained only an orbiter and impactor designed to slam into the lunar surface.
Plummeting costs: The budget for the mission is just $141 million, indicating just how cheap it has become to send things into space.
Want to stay up to date with space tech news? Sign up for our newsletter, The Airlock.
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
The dark secret behind those cute AI-generated animal images
Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.